CAH on NYSE

Cardinal Health

Logo: Cardinal Health, Public domain, via Wikimedia Commons6

American multinational health care services company

Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products.3 It was founded by Robert D. Walter.1 Its shares trade on NYSE under the symbol CAH.1 Wikipedia text CC BY-SA 4.0

$253.88 up 0.17 (0.07%)Price as of Oct 16, 2026 at 19:58 UTC

Last updated Oct 21, 2026.

Overview

$254.2BRevenue, fiscal 20267
$1.7BNet income, fiscal 20267
1971Founded1

Compare with Cencora, McKesson Corporation or Herbalife, or pick any stock.

  • TickerCAH on NYSE1
  • Industryhealth care1
  • HeadquartersDublin1
  • Websitewww.cardinalhealth.com
  • Incorporated inOH8
  • Business address7000 Cardinal Place, Dublin, Oh 430178
  • Filer categoryLarge accelerated filer8
  • Legal formCorporation (For-Profit)4
  • LEICCU46N3GJMF4OK4N7U604
  • StatusActive4
  • LEI statusIssued and current4
  • Registered addressC/O CT CORPORATION SYSTEM, 43219 Columbus, United States4
  • Registered withCorporation Database (Ohio Secretary of State), 5356134
Cardinal Health headquarters (Dublin, Ohio)
Photo: Nheyob, CC BY-SA 4.0, via Wikimedia Commons11

Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

3.8%Gross margin7
1.0%Operating margin7
0.7%Net margin7
14.2%Revenue growth, 20267
$4.5BFree cash flow7

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Pharmaceutical and Specialty Solutions brought in 92% of the revenue Cardinal Health broke down this way in fiscal 2026.

  1. Pharmaceutical and Specialty Solutions$234.8B792%up 15% from 2025
  2. GMPD$12.7B75%up 1% from 2025
  3. Other Operating$6.8B73%up 26% from 2025
Business segments by year
Business segments202420252026
Pharmaceutical and Specialty Solutions$210.0B$204.6B$234.8B
GMPD$12.4B$12.6B$12.7B
Other Operating$4.5B$5.4B$6.8B

Regions

United States brought in 99% of the revenue Cardinal Health broke down this way in fiscal 2026.

  1. United States$252.6B799%up 14% from 2025
  2. Outside the United States$1.7B71%up 2% from 2025
Regions by year
Regions202420252026
United States$225.2B$221.0B$252.6B
Outside the United States$1.7B$1.7B$1.7B

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue97¢$244.5B
  • Selling, general and admin2¢$6.1B
  • Interest0¢$348.0M
  • Income tax0¢$469.0M
  • Profit1¢$1.7B

Out of $254.2B in revenue.7

Where each dollar of operating cash went, fiscal 2026

  • Capital spending13¢$649.0M
  • Dividends paid9¢$491.0M
  • Share buybacks26¢$1.4B
  • Kept or used elsewhere52¢$2.7B

Out of $5.2B of cash from operations.7

Financial statements

Revenue12131415167$254.2B in 2026+75% since 2019
0$100.0B$200.0B$300.0B2019: $145.5B$145.5B20192020: $152.9B$152.9B2020+5%2021: $162.5B$162.5B2021+6%2022: $181.3B$181.3B2022+12%2023: $205.0B$205.0B2023+13%2024: $226.8B$226.8B2024+11%2025: $222.6B$222.6B2025−2%2026: $254.2B$254.2B2026+14%
Gross profit12131415167$9.8B in 2026+43% since 2019
0$2.5B$5.0B$7.5B$10.0B2019: $6.8B$6.8B20192020: $6.9B$6.9B2020+0%2021: $6.8B$6.8B2021−1%2022: $6.5B$6.5B2022−4%2023: $6.9B$6.9B2023+6%2024: $7.4B$7.4B2024+8%2025: $8.2B$8.2B2025+10%2026: $9.8B$9.8B2026+20%
Operating income12131415167$2.6B in 2026+27% since 2019
-$6.0B-$4.0B-$2.0B0$2.0B$4.0B2019: $2.1B$2.1B20192020: -$4.1B-$4.1B20202021: $472.0M$472.0M20212022: -$607.0M-$607.0M20222023: $752.0M$752.0M20232024: $1.2B$1.2B2024+65%2025: $2.3B$2.3B2025+83%2026: $2.6B$2.6B2026+15%
Net income12131415167$1.7B in 2026+26% since 2019
-$4.0B-$2.0B0$2.0B2019: $1.4B$1.4B20192020: -$3.7B-$3.7B20202021: $611.0M$611.0M20212022: -$938.0M-$938.0M20222023: $330.0M$330.0M20232024: $852.0M$852.0M2024+158%2025: $1.6B$1.6B2025+83%2026: $1.7B$1.7B2026+10%

Every line of the income statement as filed: the last 3 fiscal years, latest first.7

Period ending2026-06-302025-06-302024-06-30
Revenue$254.2B$222.6B$226.8B
Cost of products sold$244.5B$214.4B$219.4B
Gross margin$9.8B$8.2B$7.4B
Distribution, selling, general, and administrative expenses$6.1B$5.4B$5.0B
Restructuring and employee severance$106.0M$88.0M$175.0M
Amortization and other acquisition-related costs$469.0M$464.0M$284.0M
Acquisition-related cash and share-based compensation costs [Line Items]$287.0M$126.0M$0
Impairments and (gain)/loss on disposal of assets, net$177.0M$18.0M$634.0M
Litigation (recoveries)/charges, net-$10.0M-$185.0M$78.0M
Operating earnings$2.6B$2.3B$1.2B
Other (income)/expense, net-$31.0M-$41.0M-$9.0M
Interest expense, net$348.0M$215.0M$51.0M
Equity Method Investment, Other-than-Temporary Impairment$122.0M$0$0
Earnings before income taxes$2.2B$2.1B$1.2B
Income Tax Expense (Benefit)$469.0M$532.0M$348.0M
Net earnings$1.7B$1.6B$853.0M
Less: Net (earnings)/loss attributable to noncontrolling interests$9.0M-$8.0M-$1.0M
Net earnings attributable to Cardinal Health, Inc.$1.7B$1.6B$852.0M
Basic (in dollars per share)$7.27$6.48$3.48
Diluted (in dollars per share)$7.23$6.45$3.45
Basic (in shares)236.0M shares241.0M shares245.0M shares
Diluted (in shares)237.0M shares242.0M shares247.0M shares

Compare Cardinal Health with another company

Corporate structure

Cardinal Health sits at the top of its group. 123 entities, 31 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Cardinal Health

  • Cardinal Health Dublin, Ohio, United States
    • Cardinal Health (Australia) Subsidiary · Melbourne, Australia
    • Cardinal Health (Switzerland) Subsidiary · Rolle, Switzerland
    • A+ Secure Packaging, LLC Subsidiary · Tennessee, United States
    • Aero-Med, LLC Subsidiary · Connecticut, United States
    • Allegiance Corporation Subsidiary · Delaware, United States
    • Cardinal Health 100, LLC Subsidiary · Indiana, United States
    • Cardinal Health 104 LP Subsidiary · Ohio, United States
    • Cardinal Health 105, LLC Subsidiary · Ohio, United States
    • Cardinal Health 107, LLC Subsidiary · Ohio, United States
    • Cardinal Health 108, LLC Subsidiary · Delaware, United States
    • Cardinal Health 110, LLC Subsidiary · Delaware, United States
    • Cardinal Health 112, LLC Subsidiary · Delaware, United States
    • Cardinal Health 113, LLC Subsidiary · Wisconsin, United States
    • Cardinal Health 114, Inc. Subsidiary · Delaware, United States
    • Cardinal Health 115, LLC Subsidiary · Ohio, United States
    • Cardinal Health 116, LLC Subsidiary · Delaware, United States
    • Cardinal Health 118, LLC Subsidiary · Delaware, United States
    • Cardinal Health 119, LLC Subsidiary · Delaware, United States
    • Cardinal Health 121, LLC Subsidiary · Delaware, United States
    • Cardinal Health 122, LLC Subsidiary · Delaware, United States
    • Cardinal Health 123, LLC Subsidiary · Delaware, United States
    • Cardinal Health 124, LLC Subsidiary · Delaware, United States
    • Cardinal Health 126, LLC Subsidiary · Delaware, United States
    • Cardinal Health 127, Inc. Subsidiary · Kansas, United States
    • Cardinal Health 132, LLC Subsidiary · Delaware, United States
    • and 97 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Cardinal Health reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$8.0B7 Jun 30, 2026$7.5B7 Jun 30, 2025+6.0%
Accumulated depreciation$4.9B7 Jun 30, 2026$4.7B7 Jun 30, 2025+5.9%
Property and equipment, net$3.0B7 Jun 30, 2026$2.9B7 Jun 30, 2025+6.1%
Finance-lease assets$175.0M7 Jun 30, 2026$192.0M7 Jun 30, 2025−8.9%
Operating-lease assets (leased space)$991.0M7 Jun 30, 2026$758.0M7 Jun 30, 2025+30.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$4.9B7 Jun 30, 2026$3.9B7 Jun 30, 2025+25.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$11.4B7 Jun 30, 2026$9.7B7 Jun 30, 2025+18.1%
Intangible assets, net (excluding goodwill)$2.2B7 Jun 30, 2026$2.5B7 Jun 30, 2025−11.9%
Indefinite-lived intangibles (excluding goodwill)$24.0M7 Jun 30, 2026$13.0M7 Jun 30, 2025+84.6%
Finite-lived intangibles, gross$6.3B7 Jun 30, 2026$6.3B7 Jun 30, 2025+0.5%
Accumulated amortization$4.2B7 Jun 30, 2026$3.8B7 Jun 30, 2025+8.8%
Finite-lived intangibles, net$2.2B7 Jun 30, 2026$2.5B7 Jun 30, 2025−12.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$17.3B7 Jun 30, 2026$16.8B7 Jun 30, 2025+2.8%

The story

Founded by Robert D. Walter in 1971.1

History

Founded in 1971 as Cardinal Foods by Robert D. Walter, the company was initially a food wholesaler. After acquiring the Bailey Drug Company in 1979, it began whole selling drugs. The company went public on the NASDAQ stock exchange in 1983.

In 1988, Walter sold Cardinal Health's food operations to Roundy's. From 1991 to 1996, the company's sales grew from $1.2 billion to $8.9 billion. The company changed its name to Cardinal Health in 1994, and became the third-largest pharmaceutical wholesaler in the United States.

2000–2019

R. Kerry Clark, a former executive and vice chairman at Procter & Gamble, was appointed president and CEO in April 2006, with Robert D. Walter retaining Chairmanship of the board. In September 2008, the company announced Clark and Walter would retire and George S. Barrett would become the chairman and CEO.

In 2009, Cardinal Health completed the spin-off of its clinical and medical products businesses into an independent medical technology company called CareFusion with David Schlotterbeck as CEO. Cardinal Health is now traded on the NYSE under symbol CAH.

In December 2013, it was announced that Cardinal Health would partner with CVS Caremark to form a generic drug sourcing operation in the United States. The venture was named Red Oak Sourcing and began operations in July 2014.

Between 2014 and 2016, Cardinal, alongside McKesson Corporation, and AmerisourceBergen, spent $13 million lobbying Congress to pass Congressman Tom Marino's "Ensuring Patient Access and Effective Drug Enforcement Act". The bill, which increases the burden of proof enforcers need to show against drug distributors, was signed into law by President Barack Obama in April 2016.

In January 2018, Michael Kaufmann assumed the role of CEO after serving as CFO of the company.

Opioid lawsuits

In 2019, Cardinal was one of several drug distributors named in lawsuits related to the opioid crisis in the US. In July 2021, Cardinal Health and other pharmaceutical companies agreed to participate in a $26 billion settlement. Cardinal will pay $6.4 billion over 18 years.

Read the full text

In May 2020, Oklahoma Attorney General Mike Hunter sued Cardinal Health in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis. The suit was filed along with lawsuits against AmerisourceBergen and McKesson, and the three lawsuits allege that the three companies provided "enough opioids to Bryan County that every adult resident there could have had 144 hydrocodone tablets."

2020–present

As of August 2021, it is ranked 14 on the Fortune 500 list with FY2020 annual revenue of $152.9 billion. The firm employs 57,000 people worldwide.

Acquisitions

In 1995, Medicine Shoppe International, the country's largest franchiser of retail pharmacies, was acquired. The merger represented the first non-distribution acquisition by Cardinal Health.

In 1996, Cardinal Health acquired Pyxis Corporation, a company that developed automated pill dispensers for hospitals, for $867 million.

In 1997, Cardinal Health planned to purchase Bergen Brunswig Corp., to which McKesson Corporation responded with a bid to purchase Amerisource. Instead, Amerisource and Bergen merged into AmerisourceBergen. Later that year, Cardinal Health completed the acquisition of Owen Healthcare, the second-largest provider of pharmacy management services in the U.S. at the time.

In 1999, the firm acquired the Chicago-based medical products manufacturer and distributor, Allegiance Healthcare (formerly a division of Baxter Healthcare). In 2001, the company acquired Bindley Western Industries, a wholesale distributor of pharmaceuticals based in Indianapolis.

In April 2006, Cardinal Health purchased Niagara Falls-based ParMed Pharmaceuticals for $40.1 million. In June 2007, the firm announced the completion of a tender offer for VIASYS Healthcare.

In June 2010, Cardinal Health announced plans to purchase Healthcare Solutions Holding, a specialty pharmaceutical services company, for $517 million. In December 2010, the company acquired Kinray, an independent pharmaceutical wholesaler, increasing Cardinal Health's presence in the independent pharmacy market by 40 percent. From 2010 to 2014, Cardinal Health acquired 18 companies including Yong Yu, a Chinese drug distributor. Cardinal sold Yong Yu in 2017 to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion.

On March 18, 2013, Cardinal Health acquired the Twinsburg, Ohio-based privately held medical supply distributor AssuraMed, and with it its subsidiaries including Edgepark Medical Supplies, for $2.7 billion. AssuraMed was backed by private equity firms Clayton, Dubilier & Rice and Goldman Sachs Alternatives.

In July 2014, Cardinal Health and CVS formed Red Oak Sourcing, the largest generic drug sourcing operation in the United States. The companies started buying generic drugs around the world to sell in U.S. markets.

In March 2015, Cardinal Health signed an agreement to acquire Johnson & Johnson's Cordis (medical) division, a cardiology and endovascular device manufacturer, for $1.94 billion. The acquisition was completed on October 4, 2015. Cardinal sold the division in August 2021 to Hellman & Friedman, a private equity firm, for $1 billion.

In April 2017, Cardinal Health announced the plan to acquire the patient product portfolio from Medtronic for $6.1 billion. The acquisition was completed on July 30, 2017.

In November 2024, Cardinal Health announced the plan to acquire Advanced Diabetes Supply Group (ADSG), a leading national direct-to-patient provider of diabetes medical supplies, for about $1.1 billion with plans to merge the company into its at-Home Solutions business. The at-Home Solutions business includes Edgepark Medical Supplies of Twinsburg, Ohio and United States Medical Supply (US MED) of Doral, Florida. The acquisition was complete by April 2024.

In August 2025, Cardinal Health announced that it would acquire a 75% stake in Solaris Health, the largest urology management services organization (MSO) in the United States, for $1.9 billion in cash.

In July 2026, Cardinal Health agreed to acquire AdaptHealth's diabetes health business and medical-supply provider Strive Medical in separate transactions worth approximately US$360 million in total. The acquisitions were intended to expand its at-Home Solutions business in diabetes and urological care.

Cardinal Health Foundation

The Cardinal Health Foundation is the charitable arm of Cardinal Health. The company makes annual product donations of over $9 million through international relief organizations and provides up to $1,000 in matching funds for every Cardinal Health employee that makes a charitable donation. In 2008, the foundation established its E3 Grant Program. Over the past seven years, the Foundation has invested more than $7.15 million in funding to 241 hospitals, health systems or other health-related organizations.

Cardinal Health also supports organizations such as Ronald McDonald House Charities, and was named Benefactor of the Year at the 2011 Corporate Caring Awards. In 2015, the foundation contributed $3 million to the Solutions for Patient Safety project, which has raised over $11 million nationally for efforts to improve safety initiatives in children's hospitals.

From Wikipedia’s article on Cardinal Health, shared under CC BY-SA 4.0.9

Leadership

Who has led Cardinal Health, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (61)

Subsidiaries and ownership

Subsidiaries

Subsidiaries (Exhibit 21)

  • A+ Secure Packaging, LLC Tennessee10
  • Aero-Med, LLC Connecticut10
  • Allegiance Corporation Delaware10
  • Cardinal Health 100, LLC Indiana10
  • Cardinal Health 104 LP Ohio10
  • Cardinal Health 105, LLC Ohio10
  • Cardinal Health 107, LLC Ohio10
  • Cardinal Health 108, LLC Delaware10
  • Cardinal Health 110, LLC Delaware10
  • Cardinal Health 112, LLC Delaware10
  • Cardinal Health 113, LLC Wisconsin10
  • Cardinal Health 114, Inc. Delaware10
  • Cardinal Health 115, LLC Ohio10
  • Cardinal Health 116, LLC Delaware10
  • Cardinal Health 118, LLC Delaware10
  • Cardinal Health 119, LLC Delaware10
  • Cardinal Health 121, LLC Delaware10
  • Cardinal Health 122, LLC Delaware10
  • Cardinal Health 123, LLC Delaware10
  • Cardinal Health 124, LLC Delaware10
  • Cardinal Health 126, LLC Delaware10
  • Cardinal Health 127, Inc. Kansas10
  • Cardinal Health 132, LLC Delaware10
  • Cardinal Health 2, LLC Nevada10
All 118 listed subsidiaries
  • Cardinal Health 200, LLC Delaware10
  • Cardinal Health 201, LLC Delaware10
  • Cardinal Health 222 (Thailand) Ltd. Thailand10
  • Cardinal Health 23 Funding, LLC Nevada10
  • Cardinal Health 23, LLC Nevada10
  • Cardinal Health 247, Inc. Colorado10
  • Cardinal Health 249, LLC Delaware10
  • Cardinal Health 3, LLC Delaware10
  • Cardinal Health 414, LLC Delaware10
  • Cardinal Health 5, LLC Delaware10
  • Cardinal Health 6, Inc. Nevada10
  • Cardinal Health 7, LLC Delaware10
  • Cardinal Health Australia 503 Pty. Ltd. Australia10
  • Cardinal Health Austria 504 GmbH Austria10
  • Cardinal Health Belgium 505 BVBA Belgium10
  • Cardinal Health Canada Holdings Cooperative U.A. Netherlands10
  • Cardinal Health Canada Inc. Canada10
  • Cardinal Health Chile Limitada Chile10
  • Cardinal Health Colombia S.A.S. Colombia10
  • Cardinal Health D.R. 203 II Ltd. Bermuda10
  • Cardinal Health Denmark ApS Denmark10
  • Cardinal Health Finland Oy Finland10
  • Cardinal Health Foundation Ohio10
  • Cardinal Health France 506 SAS France10
  • Cardinal Health Funding, LLC Nevada10
  • Cardinal Health Germany 507 GmbH Germany10
  • Cardinal Health Germany Manufacturing GmbH Germany10
  • Cardinal Health IPS, LLC Delaware10
  • Cardinal Health International India Private Limited India10
  • Cardinal Health International Philippines, Inc. Philippines10
  • Cardinal Health Ireland 419 Designated Activity Company Ireland10
  • Cardinal Health Ireland 508 Limited Ireland10
  • Cardinal Health Ireland Unlimited Company Ireland10
  • Cardinal Health Italy 509 Srl Italy10
  • Cardinal Health K.K. Japan10
  • Cardinal Health Malaysia 211 Sdn. Bhd. Malaysia10
  • Cardinal Health Malta 212 Limited Malta10
  • Cardinal Health Managed Care Services, LLC Delaware10
  • Cardinal Health Medical Equipment Consulting (Shanghai) Co., Ltd. China10
  • Cardinal Health Mexico 514 S. de R.L. de C.V. Mexico10
  • Cardinal Health Middle East FZ-LLC United Arab Emirates10
  • Cardinal Health Netherlands 502 B.V. Netherlands10
  • Cardinal Health P.R. 120, Inc. Puerto Rico10
  • Cardinal Health P.R. 218, Inc. Puerto Rico10
  • Cardinal Health P.R. 220, LLC Puerto Rico10
  • Cardinal Health Pharmaceutical Contracting, LLC Delaware10
  • Cardinal Health Pharmacy Services, LLC Delaware10
  • Cardinal Health Singapore 225 Pte. Ltd. Singapore10
  • Cardinal Health Spain 511 S.L. Spain10
  • Cardinal Health Sweden 512 A.B. Sweden10
  • Cardinal Health Switzerland 515 GmbH Switzerland10
  • Cardinal Health Systems, Inc. Ohio10
  • Cardinal Health Technologies Switzerland GmbH Switzerland10
  • Cardinal Health Technologies, LLC Nevada10
  • Cardinal Health U.K. 432 Limited United Kingdom10
  • Cardinal Health do Brasil Ltd. Brazil10
  • Cirpro de Delicias S.A. de C.V. Mexico10
  • Convertors de Mexico S.A. de C.V. Mexico10
  • Cordis (Shanghai) Medical Devices Co., Ltd. China10
  • Cordis Corporation Florida10
  • Cornerstone Rheumatology, L.P. Tennessee10
  • Covidien Manufacturing Solutions, S.A. Costa Rica10
  • EPIC Insurance Company Vermont10
  • Especialidades Medicas Kenmex S.A. de C.V. Mexico10
  • GastroGPO, LLC Delaware10
  • Gastrologix, LLC Delaware10
  • Griffin Capital, LLC Nevada10
  • Innovative Therapies, LLC Delaware10
  • Instant Diagnostic Systems, Inc. Alabama10
  • KPR Australia Pty. Ltd. Australia10
  • KPR U.S., LLC Delaware10
  • Kendall-Gammatron Limited Thailand10
  • Leader Drugstores, Inc. Delaware10
  • Ludlow Technical Products Canada, Ltd. Canada10
  • Marin Apothecaries California10
  • Medicine Shoppe International, Inc. Delaware10
  • Mediquip Sdn. Bhd. Malaysia10
  • MosaicGPO, LLC Delaware10
  • One Cloverleaf, LLC Delaware10
  • Pinnacle Intellectual Property Services, Inc. Nevada10
  • Pinnacle Intellectual Property Services-International, Inc. Nevada10
  • Quiroproductos de Cuauhtemoc S. de R.L. de C.V. Mexico10
  • RGH Enterprises, LLC Ohio10
  • RainTree GPO, LLC Delaware10
  • Renal Purchasing Group, LLC Tennessee10
  • Rxealtime, Inc. Nevada10
  • Sonexus Health, LLC Texas10
  • Specialty Networks Urology Registry, LLC Delaware10
  • The Harvard Drug Group, L.L.C. Michigan10
  • Traverse GPO, LLC Delaware10
  • United Rheumatology, LLC Delaware10
  • UroGPO, LLC Delaware10
  • WaveMark, Inc. Delaware10
  • mscripts, LLC Delaware10

From Wikidata.1 The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • CARDINAL HEALTH INCAug 19, 1994 to Oct 1, 20268
  • CARDINAL DISTRIBUTION INCFeb 16, 1994 to Feb 17, 19948

Timeline

  1. Oct 1, 20268-K Regulation FD disclosure99
  2. Aug 11, 20268-K Entered a material agreement; Ended a material agreement; New debt or obligation100
  3. Aug 11, 20268-K Results of operations; Regulation FD disclosure101
  4. Aug 5, 20268-K Executive or director change102
  5. Apr 30, 20268-K Results of operations; Regulation FD disclosure103
  6. Mar 23, 20268-K Executive or director change; Regulation FD disclosure104
  7. Mar 5, 20268-K Executive or director change105
  8. Feb 5, 20268-K Results of operations; Regulation FD disclosure106
  9. Jan 13, 20268-K Regulation FD disclosure107
  10. Nov 6, 20258-K Shareholder vote108
  11. Oct 30, 20258-K Results of operations; Regulation FD disclosure109
  12. Oct 10, 20258-K Entered a material agreement110
  13. May 17, 2023New chief executive Jason Hollar becomes CEO20
  14. Sep 29, 2022New chief executive Deborah Weitzman becomes CEO21
  15. Aug 26, 2019New chief executive Stephen M. Mason becomes CEO22
  16. Nov 19, 2018New chief executive Victor L. Crawford becomes CEO23
  17. Nov 18, 2014New chief executive Jon L. Giacomin becomes CEO24
  18. Apr 18, 2012New chief executive Donald M. Casey Jr. becomes CEO25
  19. Sep 2, 2009New chief executive Mike Kaufmann becomes CEO26
  20. Feb 1, 2008New chief executive George Barrett becomes CEO27
  21. Nov 13, 2006New chief executive Mark W. Parrish becomes CEO32
  22. Aug 17, 2006New chief executive David L. Schlotterbeck becomes CEO31
  23. Apr 19, 2006New chief executive Kerry Clark becomes CEO30
  24. Feb 1, 2006New chief executive Ronald K. Labrum becomes CEO29
  25. Jan 17, 2006New chief executive Robert D. Walter becomes CEO28
  26. 1971Founded Founded1

Calendar

Coming up

  1. Nov 5, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported $2.55 a share, on Oct 30, 2025.111

When it reported results

  1. Aug 11, 2026Reported quarterly or annual results101
  2. Apr 30, 2026Reported quarterly or annual results103
  3. Feb 5, 2026Reported quarterly or annual results106
  4. Oct 30, 2025Reported quarterly or annual results109
  5. Aug 12, 2025Reported quarterly or annual results112
  6. May 1, 2025Reported quarterly or annual results113
  7. Jan 30, 2025Reported quarterly or annual results114
  8. Nov 1, 2024Reported quarterly or annual results115

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

410 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 62 major events, 217 insider forms, 23 large holders, 88 other. The latest 20:

  1. Oct 1, 20268-K EDGAR
  2. Sep 21, 2026ARS ANNUAL REPORT TO SECURITY HOLDERS EDGAR
  3. Sep 21, 2026DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS EDGAR
  4. Sep 21, 2026DEF 14A DEFINITIVE PROXY STATEMENT EDGAR
  5. Aug 20, 20264 EDGAR
  6. Aug 20, 20264 EDGAR
  7. Aug 20, 20264 EDGAR
  8. Aug 20, 20264 EDGAR
  9. Aug 20, 20264 EDGAR
  10. Aug 20, 20264 EDGAR
  11. Aug 20, 20264 EDGAR
  12. Aug 19, 2026144 EDGAR
  13. Aug 18, 20264 EDGAR
  14. Aug 18, 20264 EDGAR
  15. Aug 18, 20264 EDGAR
  16. Aug 18, 20264 EDGAR
  17. Aug 18, 20264 EDGAR
  18. Aug 18, 20264 EDGAR
  19. Aug 18, 20264 EDGAR
  20. Aug 18, 20264 EDGAR

The 410 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

46 open-market trades by officers, directors and large owners since October 2021: 5 buys and 41 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 19, 2026Scherer Mary C.Chief Accounting OfficerSale2,302$237.39$546.5KForm 4
Aug 19, 2026Hollar Jason M.Chief Executive OfficerSale44,529$236.18$10.5MForm 4
Aug 18, 2026Greene Michelle D.Chief Information OfficerSale11,650$235.72$2.7MForm 4
Aug 18, 2026WEITZMAN DEBORAHCEO, PSS SegmentSale7,354$235.45$1.7MForm 4
Aug 18, 2026Mason Stephen MCEO, GMPD SegmentSale35,000$236.40$8.3MForm 4
Aug 18, 2026Mayer Jessica LChief Legal/Compliance OfficerSale29,436$236.19$7.0MForm 4
Aug 18, 2026Alt Aaron EChief Financial OfficerSale42,000$236.34$9.9MForm 4
Aug 18, 2026Hollar Jason M.Chief Executive OfficerSale80,000$235.74$18.9MForm 4
Feb 27, 2026Greene Michelle D.Chief Information OfficerSale2,746$228.47$627.4KForm 4
Feb 18, 2026Alt Aaron EChief Financial OfficerSale2,328$225.50$525.0KForm 4
Feb 6, 2026Hall Patricia HemingwayDirectorSale4,000$229.72$918.9KForm 4
Aug 20, 2025WEITZMAN DEBORAHCEO, PSS SegmentSale21,367$150.53$3.2MForm 4
Aug 20, 2025Hollar Jason M.Chief Executive OfficerSale35,901$150.04$5.4MForm 4
Aug 19, 2025Scherer Mary C.Chief Accounting OfficerSale6,766$149.25$1.0MForm 4
Aug 19, 2025Greene Michelle D.Chief Information OfficerSale13,500$148.82$2.0MForm 4
Aug 19, 2025Mason Stephen MCEO, GMPD SegmentSale41,575$148.82$6.2MForm 4
Aug 19, 2025Hollar Jason M.Chief Executive OfficerSale107,705$148.90$16.0MForm 4
Aug 19, 2025Mayer Jessica LChief Legal/Compliance OfficerSale38,078$148.82$5.7MForm 4
Aug 19, 2025Alt Aaron EChief Financial OfficerSale48,243$148.78$7.2MForm 4
Aug 19, 2025Snow Ola MChief Human Resources OfficerSale28,151$148.94$4.2MForm 4

All 46 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2026Jason M. Hollar$1.5M$22.6M124
2026Aaron E. Alt$896.2K$6.9M124
2026Deborah L. Weitzman$770.5K$6.1M124
2026Jessica L. Mayer$741.2K$5.5M124
2026Stephen M. Mason$762.0K$5.3M124
2025Chief Executive Officer$1.5M$19.0M124
2025Chief Financial Officer$871.2K$6.2M124
2025Chief Legal and Compliance Officer$716.9K$4.9M124
2024Chief Executive Officer$1.4M$25.7M124
2024Chief Financial Officer$846.0K$6.8M124
2024Chief Legal and Compliance Officer$696.0K$4.7M124

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.26,490,633$6.3B0.1%−2,004,222
Vanguard Capital Management LLC15,292,186$3.6B0.1%+3,477
Wellington Management Group Llp14,860,271$3.5B0.6%+10,584,119
Vanguard Portfolio Management LLC13,717,894$3.3B0.1%−14,415
State Street Corp11,967,121$2.8B0.1%−107,397
Geode Capital Management, LLC6,472,810$1.5B0.1%−107,722
Invesco Ltd.4,742,576$1.1B0.1%+1,230,335
Morgan Stanley4,625,329$1.1B0.1%−328,999
Wcm Investment Management, LLC4,112,461$971.4M1.8%+105,825
Norges Bank3,726,422$885.2M0.1%New
Bank Of America Corp /de/2,900,596$689.1M0.0%+18,831
Northern Trust Corp2,868,903$681.5M0.1%+74,596
Jpmorgan Chase & Co2,668,749$630.4M0.0%+352,105
Goldman Sachs Group Inc2,385,033$566.6M0.1%+13,179
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC2,224,578$528.5M0.1%−97,860
Bnp Paribas Financial Markets2,103,149$499.6M0.3%+599,252
Fmr LLC2,066,248$490.9M0.0%−2,176,992
Victory Capital Management Inc1,977,579$469.8M0.3%+590,745
Legal & General Group Plc1,847,406$438.9M0.1%−192,520
Aqr Capital Management LLC1,732,808$411.6M0.1%+143,038
Charles Schwab Investment Management Inc1,554,017$369.2M0.0%−7,137
Vanguard Fiduciary Trust Co1,328,940$315.7M0.1%−12,602
Ameriprise Financial Inc1,310,794$311.4M0.1%−228,940
Nordea Investment Management Ab1,297,534$308.7M0.3%+634,364
Bank of New York Mellon Corp1,299,209$308.6M0.1%−60,415

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

17 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Mar 27, 2026Alan ArmstrongRepublican, SenateBuy$1,001 - $15,000+1.3%Report
Oct 24, 2025Marjorie Taylor GreeneRepublican, HouseBuy$1,001 - $15,000+43.0%Report
May 14, 2025Marjorie Taylor GreeneRepublican, HouseBuy$1,001 - $15,000+39.8%Report
May 5, 2025Marjorie Taylor GreeneRepublican, HouseBuy$1,001 - $15,000+30.2%Report
Apr 8, 2025Robert P. Bresnahan, Jr.Republican, HouseBuy$1,001 - $15,000+47.8%Report
Mar 17, 2025Marjorie Taylor GreeneRepublican, HouseBuy$1,001 - $15,000+59.3%Report
Jan 21, 2025Marjorie Taylor GreeneRepublican, HouseBuy$1,001 - $15,000+70.8%Report
Sep 20, 2024Marjorie Taylor GreeneRepublican, HouseBuy$1,001 - $15,000+91.3%Report
Sep 4, 2024John JamesRepublican, HouseSale$1,001 - $15,000−83.0%Report
Jun 3, 2024John JamesRepublican, HouseBuy$1,001 - $15,000+109.1%Report
May 2, 2024John JamesRepublican, HouseBuy$1,001 - $15,000+93.9%Report
Jan 12, 2024Jonathan L. JacksonDemocratic, HouseBuy$50,001 - $100,000+78.2%Report
Aug 3, 2022Kathy Manning, HouseSale$1,001 - $15,000−236.0%Report
Jul 20, 2022Kathy Manning, HouseBuy$1,001 - $15,000+260.7%Report
Apr 7, 2020Kelly Loeffler, SenateBuy$1,001 - $15,000−239.5%Report
Apr 7, 2020Kelly Loeffler, SenateSale$100,001 - $250,000−239.5%Report
Mar 20, 2020Kelly Loeffler, SenateBuy$100,001 - $250,000+249.0%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

SEC filer profile

How Cardinal Health is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCARDINAL HEALTH INC2
  • CIK0000721371
  • Employer ID (EIN)31-0958666125
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company125
  • Incorporated inOhio125
  • Fiscal year endsJune 302
  • Industry code (SIC)5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries2
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance2
  • Business address7000 Cardinal Place, Dublin, OH 430172
  • Phone61475730332
  • Shares outstanding232,575,728 shares as of Jul 31, 2026125
  • Public float$48.2B as of Dec 31, 2025125
  • AuditorErnst & Young LLP, Grandview Heights, Ohio PCAOB ID 42; it also attests to the company’s internal control over financial reporting125
  • On EDGAR sinceFeb 9, 19942
  • Filings2,613 in all: 4 (1,314), 8-K (356), 10-Q (98), SC 13G/A (98), 11-K (73), 3 (67), S-8 POS (45), 144 (38)2
    All 62 form types

    S-8 (37), SC 13G (36), DEF 14A (34), DEFA14A (32), 10-K (31), 425 (23), UPLOAD (23), 424B5 (19), 8-K/A (18), 4/A (16), 424B3 (16), ARS (15), CORRESP (15), PX14A6G (15), S-4 (14), SC TO-T/A (13), 5 (12), PRE 14A (12), SD (12), 424B2 (11), FWP (11), S-4/A (9), SC 13D (9), SC TO-C (8), NO ACT (7), S-3 (7), S-3ASR (7), 11-K/A (5), SC TO-I/A (5), SCHEDULE 13G (5), 10-K/A (4), S-3/A (4), SC 13D/A (4), SCHEDULE 13G/A (4), 11-KT (3), SC TO-T (3), 10-C (2), 10-K405 (2), 15-12B (2), 3/A (2), 424B1 (2), EFFECT (2), REGDEX/A (2), 10-Q/A (1), 15-12G (1), 424A (1), 8-A12B (1), D/A (1), DEFM14A (1), NT 10-K (1), POS AM (1), REGDEX (1), RW (1), SC TO-I (1)

  • Latest filingsAnnual report (10-K) Aug 11, 2026
    Quarterly report (10-Q) Apr 30, 2026
    Proxy statement (DEF 14A) Sep 21, 2026
    Latest 8-K (8-K) Oct 1, 2026

Securities registered for trading

ClassSymbolExchange
Common shares (without par value)CAHNew York Stock Exchange

From the cover page of the 10-K filed Aug 11, 2026 (Section 12(b) of the Exchange Act).125

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Yahoo FinanceCAH quote
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
    Wikidata and SEC EDGARChristine Mundkur, Board member
  66. 66
    Wikidata and SEC EDGARMichelle Brennan, Board member
  67. 67
    Wikidata and SEC EDGARSteven Barg, Board member
  68. 68
    Wikidata and SEC EDGARSuja Chandrasekaran, Board member
  69. 69
    Wikidata and SEC EDGARDave Evans, Board member
  70. 70
    Wikidata and SEC EDGARSheri Edison, Board member
  71. 71
    Wikidata and SEC EDGARDean A. Scarborough, Board member
  72. 72
    Wikidata and SEC EDGARJohn Weiland, Board member
  73. 73
    Wikidata and SEC EDGARMike Kaufmann, Board member
  74. 74
    Wikidata and SEC EDGARAkhil Johri, Board member
  75. 75
    Wikidata and SEC EDGARNancy Killefer, Board member
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
    Wikidata and SEC EDGARBruce Downey, Board member
  81. 81
  82. 82
    Wikidata and SEC EDGARCarrie Cox, Board member
  83. 83
    Wikidata and SEC EDGARGregory Kenny, Board member
  84. 84
  85. 85
  86. 86
  87. 87
  88. 88
  89. 89
  90. 90
  91. 91
  92. 92
  93. 93
  94. 94
  95. 95
  96. 96
  97. 97
  98. 98
  99. 99
  100. 100
  101. 101
  102. 102
  103. 103
  104. 104
  105. 105
  106. 106
  107. 107
  108. 108
  109. 109
  110. 110
  111. 111
  112. 112
  113. 113
  114. 114
  115. 115
  116. 116
  117. 117
  118. 118
  119. 119
  120. 120
  121. 121
  122. 122
  123. 123
  124. 124
  125. 125